{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "regularMarketChangePercent": -2.343751, "regularMarketPrice": 0.1875, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.09, "sharesOutstanding": 16100000, "fiftyDayAverage": 0.1941, "fiftyDayAverageChange": -0.0066000074, "fiftyDayAverageChangePercent": -0.034003127, "twoHundredDayAverage": 0.2147475, "twoHundredDayAverageChange": -0.027247503, "twoHundredDayAverageChangePercent": -0.12688158, "marketCap": 3489525, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "prevName": "Modus Therapeutics Holding Ab", "nameChangeDate": "2023-05-11", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1627884000000, "priceHint": 4, "marketState": "REGULAR", "exchange": "FRA", "shortName": "MODUS THERAPEUTICS HLDG", "longName": "Modus Therapeutics Holding AB (publ)", "messageBoardId": "finmb_710504780", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChange": -0.0045000017, "regularMarketTime": 1683871385, "regularMarketDayHigh": 0.1875, "regularMarketDayRange": "0.1875 - 0.1875", "regularMarketDayLow": 0.1875, "regularMarketVolume": 1000, "regularMarketPreviousClose": 0.192, "bid": 0.202, "ask": 0.227, "fullExchangeName": "Frankfurt", "financialCurrency": "SEK", "regularMarketOpen": 0.1875, "averageDailyVolume3Month": 254, "averageDailyVolume10Day": 100, "fiftyTwoWeekLowChange": 0.0325, "fiftyTwoWeekLowChangePercent": 0.20967741, "fiftyTwoWeekRange": "0.155 - 0.446", "fiftyTwoWeekHighChange": -0.2585, "fiftyTwoWeekHighChangePercent": -0.5795964, "fiftyTwoWeekLow": 0.155, "fiftyTwoWeekHigh": 0.446, "symbol": "99Z.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Olof Palmes gata 29 IV", "city": "Stockholm", "zip": "11122", "country": "Sweden", "phone": "46 8 50 13 70 00", "website": "https://www.modustx.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. Its lead product is Sevuparin, a lipopolysaccharide to treat patients with sepsis, septic shock, and other systemic inflammation conditions, which is under Phase Ib clinical study. The company was founded in 2011 and is headquartered in Stockholm, Sweden.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Dr. John  \u00d6hd M.D., Ph.D.", "age": 51, "title": "Chief Exec. Officer", "yearBorn": 1971, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Claes  Lindblad", "age": 55, "title": "Chief Financial Officer", "yearBorn": 1967, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}